Progeria, rapamycin and normal aging: recent breakthrough.

Abstract excerpt

A recent discovery that rapamycin suppresses a pro-senescent phenotype in progeric cells not only suggests a non-toxic therapy for progeria but also implies its similarity with normal aging. For one, rapamycin is also known to suppress aging of regular human cells. Here I discuss four potential scenarios, comparing progeria with both normal and accelerated aging. This reveals further indications of rapamycin both...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Aging
• Share to Antibiotics, Antineoplastic
• Share to Cell Line